SPECIAL REPORT Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory | Reuters
ImClone Systems Biopharmaceutical Plant, New Jersey, US - Pharmaceutical Technology
Lilly to focus on new drugs in China, unload antibiotics brands and manufacturing facility for $375M | FiercePharma
Contact Us | Eli Lilly and Company
Eli Lilly & Co. History, Insulin Price Hikes & Pending Lawsuits
Eli Lilly faces federal investigation at its New Jersey plant
Eli Lilly And Other Drug Companies Boost Dividends In December | Seeking Alpha
Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody | FiercePharma
IDEA Pharma: Pharmaceutical Invention & Innovation Index 2021 | Fortune
Eli Lilly's Antibody Treatment Gets Emergency F.D.A. Approval - The New York Times
Eli Lilly to close Bridgewater facility
Eli Lilly to demolish mothballed Erbitux plant in NJ - BioProcess InternationalBioProcess International
Lilly to acquire a California-based biotech company
Putting Eli Lilly's Biotech Bounce to the Test - WSJ
Judge halts 340B dispute rule, siding with Eli Lilly in lawsuit over program | Fierce Healthcare
Eli Lilly to halt sales of 340B drugs to contract pharmacies with exception of insulin | Fierce Healthcare
Eli Lilly faces federal investigation at its New Jersey plant
Contact Us | Eli Lilly and Company
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar Stock Photo - Alamy
Eli Lilly bringing more than 400 jobs to Durham County: Report - ABC11 Raleigh-Durham
